Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-03 11:32 am Sale | 2023-02-28 | 13G | Martin Marietta Materials, Inc. MLM | BAILLIE GIFFORD & CO | 3,009,821 4.850% | -138,530![]() (-4.40%) | Filing History |
| 2023-03-03 11:28 am Sale | 2023-02-28 | 13G | Rubius Therapeutics, Inc. RUBY | BAILLIE GIFFORD & CO | 0 0.000% | -4,869,126![]() (Position Closed) | Filing History |
| 2023-03-03 11:24 am Sale | 2023-02-28 | 13G | LILIUM N.V. CORP LILMF | BAILLIE GIFFORD & CO | 17,426,855 4.670% | -1,401,722![]() (-7.44%) | Filing History |
| 2023-03-03 11:16 am Sale | 2023-02-28 | 13G | CEMEX, S.A.B. de C.V. CX | BAILLIE GIFFORD & CO | 752,914,110 4.970% | -52,493,900![]() (-6.52%) | Filing History |
| 2023-02-02 11:30 am Sale | 2023-01-31 | 13G | Nanobiotix S.A. NBTX | BAILLIE GIFFORD & CO | 1,513,207 4.340% | -230,919![]() (-13.24%) | Filing History |
| 2023-01-30 07:11 am Purchase | 2022-12-30 | 13G | Duolingo, Inc. DUOL | BAILLIE GIFFORD & CO | 3,252,753 10.400% | 183,200![]() (+5.97%) | Filing History |
| 2023-01-30 07:06 am Purchase | 2022-12-30 | 13G | CEMEX, S.A.B. de C.V. CX | BAILLIE GIFFORD & CO | 805,408,010 5.320% | 805,408,010![]() (New Position) | Filing History |
| 2023-01-25 08:47 am Purchase | 2022-12-30 | 13G | Wix.com Ltd. WIX | BAILLIE GIFFORD & CO | 8,046,560 13.690% | 4,781,622![]() (+146.45%) | Filing History |
| 2023-01-25 08:43 am Sale | 2022-12-30 | 13G | Jumia Technologies AG JMIA | BAILLIE GIFFORD & CO | 18,752,984 9.390% | -1,092,228![]() (-5.50%) | Filing History |
| 2023-01-25 06:38 am Sale | 2022-12-30 | 13G | Mobileye Global Inc. MBLY | BAILLIE GIFFORD & CO | 6,182,361 11.910% | -8,115![]() (-0.13%) | Filing History |
| 2023-01-25 06:34 am Unchanged | 2022-12-30 | 13G | MELI Kaszek Pioneer Corp MEKA | BAILLIE GIFFORD & CO | 2,000,000 6.730% | 0 (Unchanged) | Filing History |
| 2023-01-24 09:25 am Purchase | 2022-12-30 | 13G | LILIUM N.V. CORP LILMF | BAILLIE GIFFORD & CO | 18,828,577 5.110% | 756,362![]() (+4.19%) | Filing History |
| 2023-01-24 07:35 am Purchase | 2022-12-30 | 13G | Recursion Pharmaceuticals, Inc. RXRX | BAILLIE GIFFORD & CO | 24,820,850 13.660% | 2,697,695![]() (+12.19%) | Filing History |
| 2023-01-23 11:31 am Purchase | 2022-12-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | BAILLIE GIFFORD & CO | 6,104,416 18.030% | 3,132,526![]() (+105.41%) | Filing History |
| 2023-01-23 11:19 am Purchase | 2022-12-30 | 13G | Warby Parker Inc. WRBY | BAILLIE GIFFORD & CO | 6,282,549 6.550% | 640,088![]() (+11.34%) | Filing History |
| 2023-01-23 11:14 am Purchase | 2022-12-30 | 13G | Upwork Inc. UPWK | BAILLIE GIFFORD & CO | 6,807,024 5.180% | 6,807,024![]() (New Position) | Filing History |
| 2023-01-23 11:10 am Sale | 2022-12-30 | 13G | The Trade Desk, Inc. TTD | BAILLIE GIFFORD & CO | 47,175,426 10.590% | -6,177,972![]() (-11.58%) | Filing History |
| 2023-01-23 11:03 am Sale | 2022-12-30 | 13G | The Howard Hughes Corporation HHC | BAILLIE GIFFORD & CO | 2,845,360 5.700% | -626,196![]() (-18.04%) | Filing History |
| 2023-01-23 10:54 am Purchase | 2022-12-30 | 13G | Oatly Group AB OTLY | BAILLIE GIFFORD & CO | 1,842,308 6.230% | 1,842,308![]() (New Position) | Filing History |
| 2023-01-23 10:49 am Sale | 2022-12-30 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,863,842 8.450% | -751,326![]() (-7.81%) | Filing History |

